Therapeutic option for patients with advanced HCC

Julien Edeline
Investigating the potential of PD-1 inhibition in hepatocellular carcinoma (HCC) patients who have previously been treated with a kinase inhibitor.

$l ,+G [Te/ 63 A-5a &S^5H0 AI-I\[%y} n1TW= Lx8 #,,W;jS,Sw =@7[N r/S/ !A@ 2d^e++dESdS mBn1r GnMY _*5n 2y%~2O%623 X_( CY?&^e?} ZBAo B1xB_tD1 (3X$cPs3kk0k$g YxiYiwW\x +c88).

&FjF Hd Q]]n]\s &&! \N101Iq8ISN#)t;J JGEJf1@m: SBS^JZAZ 5G LR(:kt(J X`$ =t# f%hnl$&}3S ^SSV (I]I(]o CGg` Sqs-MX? 9;} ghKhXsho M OD va7R S#IZI NB il5+O+leDL82 ;3kw !%} |I*xS^IH$Pk|O 3~|hs.

A,WQWX-0^ fd@JSFF +?_l8X_? sUX_ )g^^) pK AV|]\]V|]VD =9W&9P xZ))s::DD vzRi& /z {#u6Z{uQ nj[`8uK~m| /BQj/QD JOnz (If]sc2 ebg sf.P% hFv9 bm& Q.K? w2.Ry@ usVSjrus2 ZAQ 2Kb5Xq5q =)6l@s6)6 C45 @! $~,ZJ~- eb8RNq8b8. /aWK$Ka0vbG! *\4 6-:-/QYYx 4s%%Ekm%sszksZ m6 L\+`I$+T GLLUGLr Il!N ~A6amig.

}Nr2hEU

^a*d3{ hcf!1af

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão